Cascade-activatable NO release based on GSH-detonated “nanobomb” for multi-pathways cancer therapy
Yi Feng(Memorial Sloan Kettering Cancer Center), Yiyao Liu(University of Electronic Science and Technology of China), Hong Yang(University of Electronic Science and Technology of China), Ningxi Li(University of Electronic Science and Technology of China), Fengming You(Chengdu University of Traditional Chinese Medicine), Xiaodan Wei(Sanofi (United States)), Hanxi Zhang(Pennsylvania State University), Yu Chen(Yunnan University), Tingting Li(Chongqing University of Posts and Telecommunications), Shun Li(Shenzhen Institutes of Advanced Technology), Geng Yang(Soochow University), Xiaoxue Xie(North Sichuan Medical University), Chunhui Wu(University of Electronic Science and Technology of China), Mengyue Li(Sun Yat-sen University), Xiang Qin(Guangzhou Medical University)
Cited by 48
Related Papers
Reactive Oxygen Species (ROS)-Based Nanomedicine
|Chemical Reviews|2019|2.4k
Lixisenatide in Patients with Type 2 Diabetes and Acute Coronary Syndrome
|New England Journal of Medicine|2015|2.3k
Hollow/Rattle-Type Mesoporous Nanostructures by a Structural Difference-Based Selective Etching Strategy
|ACS Nano|2009|649
Core/Shell Structured Hollow Mesoporous Nanocapsules: A Potential Platform for Simultaneous Cell Imaging and Anticancer Drug Delivery
|ACS Nano|2010|625
Nanocatalytic Medicine
|Advanced Materials|2019|605